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Letters to the EditorPLEURODESIS TO PREVENT
MESOTHELIOMA
To the Editor:
I thank Mariette Baud, MD, and
Patricia Forgez, PhD, for their
response1 to my letter noting an
apparent lack of reported cases of
mesothelioma after previous pleuro-
desis for pneumothorax.
I agree that no ‘‘precise estimate’’
of the number of such individuals is
available but believe that ‘‘hundreds
of thousands’’ is a reasonable estimate
supporting the real possibility of a
protective effect.
Talc was reportedly first used by N.
Bethune to produce pleurodesis in
1935.2
Talc pleurodesis for the treatment of
persistent or recurrent pneumothorax
has been universally accepted since
the 1950s. The occurrence of sponta-
neous pneumothorax and its compli-
cations is a worldwide problem with
similar incidences in all nationalities.
Chest radiography equipment is
available in all of the 190 or so coun-
tries in the world, allowing diagnosis
of pneumothorax, intercostal tube
placement, and instillation of talc to
treat such complications. This has
been basic medical practice, unreliant
on high-powered technology.
Recent literature reveals many
clinical reviews dealing with this topic
from around the world, often citing
more than100 cases; for example,King-
ston, Jamaica,3 Suez Canal University
Hospital,4 Ansan Hospital, Korea,5
Basel, Switzerland,6 andSeville, Spain.7
And yet, obviously, few of the many
thousands of medical facilities around
the world providing talc pleurodesis
have published their results in the
literature.
It should also be remembered that
the risk of asbestos contamination
from early talc supplies and hence the
possibility of talc insufflation causing
mesothelioma was long recognized. It
would seem unlikely that this occur-
rence could have escaped attention.
It is of interest that all those who
have undergone talc, or similar,The Journalpleurodesis have developed well-
recognized pleural changes including
denudement of mesothelial cells,
diffuse inflammation, fibrinous
exudate, and collagen deposition. The
extent of pleural adhesion achieved is
uncertain but this is certainly incom-
plete. Therefore, it would seem likely
that any such protection frommesothe-
lioma is dependent on one or more of
the former rather than requiring exten-
sive pleural adhesion.
If such an approach was considered
justified, this would greatly simplify
provision by allowing a simple outpa-
tient insertion of a fine catheter under
local anesthetic, using appropriate im-
aging (ultrasonography) and instilla-
tion of talc slurry or similar, with
discharge after 1 to 2 hours.
There would seem to be no real
need for further consultation, exami-
nation, or investigation to attempt to
assess the extent of pleural adhesions
(pleurodesis) achieved.
Vincent Acton, MBBS(Syd),
FRANZCR
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We greatly appreciate the interest
of Keshavamurthy and colleagues1 in
our recent work.2 They emphasize the
importance of a reliable closure of the
sternum after transverse sternotomy.
Their closure technique is an inter-
esting combination of several other
closure techniques, including a bev-
eled sternotomy, pericostal sutures, a
reinforced wiring technique, and a
single figure-of-eight. This method
indeed seems sufficient to prevent
sternal dehiscence. Unfortunately,
they do not describe their outcomes
or experiences with respect to sternal
dehiscence.
Relative to transverse sternotomies,
there is far more literature concerning
the closure technique of median
sternotomies. Knowledge of several
adequate closure techniques might
improve quality of sternal closure, how-
ever, because various techniques can be
used in different clinical situations.
As outlined by Keshavamurthy and
colleagues, close attention to the
closure technique of the transverse
sternotomy may avoid sternal dehis-
cence and its associated problems.
We encourage other authors to share
the various sternal closure techniques
that they use, their experiences with
them, and the related incidences of
sternal dehiscence.
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